Quantum BioPharma has joined the trend of companies integrating cryptocurrencies into their financial strategies. On December 20, the biopharma firm announced a $1 million investment in Bitcoin and other digital currencies. Despite this move, its shares fell by nearly 10% on the Nasdaq. The company, also listed in Canada and Germany, aims to handle transactions and financing in crypto.

This shift reflects a broader trend of non-crypto businesses using digital assets to diversify and combat inflation. Meanwhile, a think tank is urging giants like Amazon and Microsoft to adopt Bitcoin, though Microsoft recently rejected such a proposal.